+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Febrile Neutropenia - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Febrile Neutropenia - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 201 Pages
  • Global
From
Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Type 1 Diabetes: Seven-Market Drug Forecast and Market Analysis

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Alzheimer's Disease (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Alzheimer's Disease (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 49 Pages
  • Global
From
Innovation Insights: Engineered Multispecific antibodies - Product Thumbnail Image

Innovation Insights: Engineered Multispecific antibodies

  • Report
  • December 2024
  • 53 Pages
  • Global
From
Glaucoma: Seven-Market Drug Forecast and Market Analysis - Update - Product Thumbnail Image

Glaucoma: Seven-Market Drug Forecast and Market Analysis - Update

  • Report
  • December 2024
  • 108 Pages
  • Global
From
Psoriatic Arthritis: Epidemiology Forecast to 2033 - Product Thumbnail Image

Psoriatic Arthritis: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 43 Pages
  • Global
From
From
Atopic Dermatitis (AD): Epidemiology Forecast to 2033 - Product Thumbnail Image

Atopic Dermatitis (AD): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 34 Pages
  • Global
From
Hepatitis C Therapeutics: Competitive Landscape - Product Thumbnail Image

Hepatitis C Therapeutics: Competitive Landscape

  • Report
  • December 2024
  • 84 Pages
  • Global
From
Gout: Opportunity Assessment and Forecast - Update - Product Thumbnail Image

Gout: Opportunity Assessment and Forecast - Update

  • Report
  • December 2024
  • 65 Pages
  • Global
From
Asthma and Severe Asthma: Epidemiology Forecast to 2033 - Product Thumbnail Image

Asthma and Severe Asthma: Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 70 Pages
  • Global
From
From
From
Hepatitis B Therapeutics: Competitive Landscape - Product Thumbnail Image

Hepatitis B Therapeutics: Competitive Landscape

  • Report
  • November 2024
  • 78 Pages
  • Global
From
Type 1 Diabetes: Epidemiology Forecast to 2033 - Product Thumbnail Image

Type 1 Diabetes: Epidemiology Forecast to 2033

  • Report
  • November 2024
  • 69 Pages
  • Global
From
Parkinson's Disease: Epidemiology Forecast to 2033 - Product Thumbnail Image

Parkinson's Disease: Epidemiology Forecast to 2033

  • Report
  • November 2024
  • 39 Pages
  • Global
From
Glomerulonephritis: Competitive Landscape - Product Thumbnail Image

Glomerulonephritis: Competitive Landscape

  • Report
  • November 2024
  • 73 Pages
  • Global
From
Idiopathic Hypersomnia (IH) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Idiopathic Hypersomnia (IH) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • October 2024
  • 55 Pages
  • Global
From
Hidradenitis Suppurativa - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Hidradenitis Suppurativa - Global Clinical Trials Review, 2024

  • Clinical Trials
  • October 2024
  • 183 Pages
  • Global
From
Glaucoma: Epidemiology Forecast to 2033 - Product Thumbnail Image

Glaucoma: Epidemiology Forecast to 2033

  • Report
  • October 2024
  • 43 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more